Anzeige
Mehr »
Login
Sonntag, 12.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Die 1 Billionen Dollar Mine: Power Nickels Weg zur globalen Dominanz!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
262 Leser
Artikel bewerten:
(1)

Sceptre Ventures Inc.: Sceptre Ventures Announces Changes to its Directors and Officers

Finanznachrichten News

Not for dissemination in the United States or for release to US news wire services

VANCOUVER, BC / ACCESSWIRE / July 14, 2021 / Sceptre Ventures Inc. ("Sceptre" and/or the "Company") (TSXV:SVP.H) announces that it has appointed Mike Hodge and Sean Charland to the Company's board of directors and Jody Bellefleur as the Company's chief financial officer and corporate secretary, effective July 12, 2021. The appointments by the Company are to fill the vacancies resulting from the resignations of Graham Abbott as a director, Trent Fedak as corporate secretary and a director, and Luis Hadic as chief financial officer. The Company would like to thank Mr. Abbott, Mr. Fedak, and Mr. Hadic for their many contributions.

Mike Hodge

Mr. Hodge brings over 20 years of experience in the private and public markets. From working in the field to raising capital, Mr. Hodge has a variety of beneficial skills he brings to the board. He is currently President and CEO of Saville Resources Inc. and a director of Zambezi Sports Inc. Mr. Hodge brings a broad range of established contacts within many different industries throughout North America, Europe, and Australia. His tireless work ethic is an asset to all the companies he works with.

Sean Charland

Mr. Charland is a seasoned communications professional with experience in raising capital and marketing resource exploration companies. He has helped raise a significant amount of capital for a variety of venture listed and private companies in mineral exploration and mining, technological and health sectors, with the majority of the focus on mineral exploration and mining. His large network of contacts within the financial community extends across North America and Europe. Mr. Charland is currently a Director of Zimtu Capital Corp., a publicly held investment issuer and company builder focused on private and small-cap resource companies. He is also the CEO and a director of Rainy Mountain Royalty Corp., a director of Core Assets Corp., a director of Arctic Star Exploration Corp., a director of Alpha Lithium Corp, a director of Binovi Technologies Corp., a director of Zinc8 Energy Solutions Inc., and Chairman and a director of Maple Gold Mines Ltd.

Jody Bellefleur

Ms. Bellefleur is a CPA with over 25 years of experience as a corporate accountant, focusing exclusively on public companies for the last 13 years. Ms. Bellefleur obtained her Bachelor of Commerce degree from the University of British Columbia in April 1994. Ms. Bellefleur is responsible for all aspects of regulatory financial reporting including the preparation of quarterly financial statements, management discussion and analysis reports, the coordination of annual audits, and government tax and regulatory reporting for multiple public companies.

About Sceptre Ventures Inc.

Sceptre Ventures Inc. is a Capital Pool Company ("CPC") within the meaning of the policies of the TSX Venture Exchange and has not commenced commercial operations and has no assets other than cash. Sceptre is currently engaged in identifying and evaluating businesses and assets with a view to completing a Qualifying Transaction under the Exchange's CPC policy.

For Further Information:

Suite 1501 - 128 West Pender Street
Vancouver, BC, V6B 1R8, Canada
Tel: 604-688-4219
Email: mitch@sceptreventures.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO SELL ANY OF THE SECURITIES DESCRIBED HEREIN IN THE UNITED STATES. THESE SECURITIES HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.

SOURCE: Sceptre Ventures Inc.



View source version on accesswire.com:
https://www.accesswire.com/655575/Sceptre-Ventures-Announces-Changes-to-its-Directors-and-Officers

© 2021 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.